BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11684961)

  • 1. Incidence, location, and significance of periprostatic and periseminal vesicle lymph nodes in prostate cancer.
    Kothari PS; Scardino PT; Ohori M; Kattan MW; Wheeler TM
    Am J Surg Pathol; 2001 Nov; 25(11):1429-32. PubMed ID: 11684961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of periprostatic and periseminal vesicle lymph node metastasis in the staging and prognosis of prostate cancer.
    Subik MK; Yao JL; di Sant'Agnese PA; Miyamoto H
    Histopathology; 2012 May; 60(6):1009-10. PubMed ID: 22372986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Early results following radical prostatectomy in patients with capsule invasion, seminal vesicle infiltration and micrometastases].
    Terhorst B; Friedrichs R
    Urologe A; 1990 Mar; 29(2):91-5. PubMed ID: 2330669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis.
    Egan AJ; Bostwick DG
    Am J Surg Pathol; 1997 Dec; 21(12):1496-500. PubMed ID: 9414194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of prostate carcinoma death in patients with lymph node metastasis.
    Cheng L; Zincke H; Blute ML; Bergstralh EJ; Scherer B; Bostwick DG
    Cancer; 2001 Jan; 91(1):66-73. PubMed ID: 11148561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seminal vesicle biopsy and laparoscopic pelvic lymph node dissection: implications for patient selection in the radiotherapeutic management of prostate cancer.
    Stock RG; Stone NN; Ianuzzi C; Unger P
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):815-21. PubMed ID: 7591888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited value of perineural invasion in radical prostatectomy specimens as a predictor of biochemical recurrence in Japanese men with clinically localized prostate cancer.
    Miyake H; Sakai I; Harada K; Eto H; Hara I
    Hinyokika Kiyo; 2005 Apr; 51(4):241-6. PubMed ID: 15912782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of lymph node metastasis and its impact on long-term prognosis in clinically localized prostate cancer.
    Arai Y; Kanamaru H; Yoshimura K; Okubo K; Kamoto T; Yoshida O
    Int J Urol; 1998 Sep; 5(5):459-65. PubMed ID: 9781435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incidence and significance of seminal vesicle invasion in patients with adenocarcinoma of the prostate.
    Mukamel E; deKernion JB; Hannah J; Smith RB; Skinner DG; Goodwin WE
    Cancer; 1987 Apr; 59(8):1535-8. PubMed ID: 3815316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of capsular perforation and seminal vesicle invasion in prostate cancer.
    Bostwick DG; Qian J; Bergstralh E; Dundore P; Dugan J; Myers RP; Oesterling JE
    J Urol; 1996 Apr; 155(4):1361-7. PubMed ID: 8632575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprostatic lymph node metastasis in prostate cancer and its clinical significance.
    Deng FM; Mendrinos SE; Das K; Melamed J
    Histopathology; 2012 May; 60(6):1004-8. PubMed ID: 22373012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in lymph node-positive prostate cancer.
    Hofer MD; Kuefer R; Huang W; Li H; Bismar TA; Perner S; Hautmann RE; Sanda MG; Gschwend JE; Rubin MA
    Urology; 2006 May; 67(5):1016-21. PubMed ID: 16698361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma.
    Mohler JL; Figlesthaler WM; Zhang XZ; Partin AW; Maygarden SJ
    Cancer; 1994 Dec; 74(11):2996-3001. PubMed ID: 7954263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience with neoadjuvant diethylstilboestrol and radical prostatectomy in patients with locally advanced prostate cancer.
    Aprikian AG; Fair WR; Reuter VE; Sogani P; Herr H; Russo P; Sheinfeld J
    Br J Urol; 1994 Nov; 74(5):630-6. PubMed ID: 7530128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microvascular invasion of the seminal vesicles in adenocarcinoma of the prostate.
    Graham SD; Napalkov P; Watts L; Salomao D; Bostwick DG
    Prostate; 1996 Jun; 28(6):359-63. PubMed ID: 8650072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel staging tool for localized prostate cancer: a pilot study using genetic adaptive neural networks.
    Tewari A; Narayan P
    J Urol; 1998 Aug; 160(2):430-6. PubMed ID: 9679892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and immunohistochemical staging of men with seminal vesicle invasion and negative pelvic lymph nodes at radical prostatectomy.
    Potter SR; Mangold LA; Shue MJ; Taylor DC; Lecksell KL; Epstein JI; Walsh PC; Partin AW
    Cancer; 2000 Dec; 89(12):2577-86. PubMed ID: 11135219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of regional lymph nodes in periprostatic fat following robot-assisted radical prostatectomy.
    Yuh B; Wu H; Ruel N; Wilson T
    BJU Int; 2012 Feb; 109(4):603-7. PubMed ID: 21851536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.